Letter to the editor: Evidence on the use of l-ornithine l-aspartate in overt HE-But does it really improve prognosis?

Hepatology. 2022 Apr;75(4):1064-1065. doi: 10.1002/hep.32309. Epub 2022 Jan 12.

Authors

Christian Labenz^{1

2}, Joachim Labenz³, Peter R Galle^{1

2}

Affiliations

¹ Department of Internal Medicine IUniversity Medical Center of the Johannes Gutenberg-UniversityMainzGermany.
² Cirrhosis Center MainzUniversity Medical Center of the Johannes Gutenberg-UniversityMainzGermany.
³ Department of Internal MedicineDiakonie-Klinikum Jung StillingSiegenGermany.

PMID: 34957567
DOI: 10.1002/hep.32309

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspartic Acid
Dipeptides
Double-Blind Method
Hepatic Encephalopathy*
Humans
Ornithine
Prognosis

Substances

Dipeptides
Aspartic Acid
Ornithine